Terms ending in 2030
Every in-force patent on Abbott Laboratories's record whose computed term ends in 2030, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 8,546,410 | Heteroaryl-Fused Macrocyclic Pyrimidine Derivatives In force · High confidence | AbbVie Inc. | In force | High confidence | |
| US 9,394,363 | Antibodies to Receptor of Advanced Glycation End Products (RAGE) and Uses Thereof In force · High confidence | AbbVie Inc. | In force | High confidence | |
| US 9,035,027 | Dual Variable Domain Immunoglobulins and Uses Thereof In force · High confidence | AbbVie Inc. | In force | High confidence | |
| US 8,420,081 | Antibody Formulations and Methods of Making Same In force · High confidence | AbbVie Biotechnology Ltd. | In force | High confidence | |
| US 8,093,396 | Benzthiazole Inhibitors of Poly(ADP-RIBOSE)polymerase In force · High confidence | AbbVie Inc. | In force | High confidence | |
| US 8,283,162 | Antibodies Relating to Pivkaii and Uses Thereof In force · High confidence | Abbott Japan LLC | In force | High confidence | |
| US 8,120,485 | Articles Containing Chipless Radio Frequency Identification Elements In force · High confidence | Abbott Laboratories | In force | High confidence | |
| US 9,398,947 | Stent Graft In force · Medium confidence | Bentley Innomed GmbH | In force | Medium confidence | |
| US D751,215 | Container In force · High confidence | Abbott Laboratories | In force | High confidence | |
| US 9,353,091 | Antiviral Compounds and Uses Thereof In force · High confidence | AbbVie Inc. | In force | High confidence | |
| 46 more term ends in 2030 · Pro | |||||
10 of 56 patents shown. Soonest term end first, then patent number.
Pro members see all 56.
14 of these are in force and held by Abbott Laboratories.
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.